Enrichment using the Phoenix Sepsis Score in children: heterogeneous treatment effects in a hydrocortisone target trial emulation

医学 败血症 氢化可的松 置信区间 内科学 队列 重症监护 队列研究 儿科 观察研究 临床试验 感染性休克 重症监护医学 休克(循环) 急诊医学 倾向得分匹配 耐火材料(行星科学) 疾病严重程度 生存分析 风险因素 随机对照试验 风险评估 优势比
作者
Lazaro Nelson Sanchez-Pinto,Robinder G. Khemani,Ngoc Duong,Mihir R. Atreya,Melania M. Bembea,Peter DeWitt,Idris V. R. Evans,Reid W. D. Farris,Edward Vincent S. Faustino,Alon Geva,Mark Hall,Christopher M. Horvat,Colin M. Rogerson,Seth Russell,Sareen Shah,Robert Scott Watson,Scott L. Weiss,Lucia C. Petito,Tellen D. Bennett
出处
期刊:Critical Care [BioMed Central]
标识
DOI:10.1186/s13054-026-06430-x
摘要

Prognostic and predictive enrichment strategies could be used to address the heterogeneity of pediatric sepsis and identify subgroups of patients most likely to benefit from targeted therapies. Our aim was to determine if the use of the Phoenix Sepsis Score (PSS) can identify critically ill children with community-acquired sepsis who are most likely to benefit from early hydrocortisone therapy. This was an observational cohort study and target trial emulation in 15 pediatric intensive care units (PICUs) in the United States, including a development cohort and replication in a validation cohort. Patients < 18 years of age admitted to a PICU with confirmed or suspected community-acquired infection between 2010 and 2019 were included. Patients who were treated with systemic stress dose hydrocortisone in the first 24 h of PICU admission were compared with untreated patients across risk groups. There were 48,345 patients included in the main analysis. A PSS ≥ 4 points in the first 12 h of PICU admission had the best discrimination of outcomes, with a 10-fold higher mortality than those with a PSS < 4 in both the development and the validation cohorts. In the target trial emulation analysis, after adjusting for covariates associated with hydrocortisone use (age, malignancy, severity of illness, refractory shock status, and hospital), patients who received early hydrocortisone and were in the high-risk phenotype (PSS ≥ 4 in first 12 h) had a lower risk of in-hospital mortality (adjusted risk ratio [aRR] 0.72 [95% confidence interval [CI] 0.65–0.80]), while low-risk patients had increased risk (aRR 1.90 [95%CI 1.66–2.16], interaction p-value < 0.001) in the development cohort. The results were replicated in the validation cohort (aRR 0.79 [95%CI 0.68, 0.92] vs. aRR 2.95 [95%CI 2.43, 3.59], interaction p-value < 0.001). A highly generalizable risk stratification strategy using the easy-to-calculate PSS can be used for both prognostic and predictive enrichment in critically ill children with community-acquired sepsis. Further external and prospective validation of our results is warranted. Not applicable.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cyan完成签到 ,获得积分10
刚刚
爱搞科研的壮壮完成签到 ,获得积分10
刚刚
Fengzhen007完成签到,获得积分10
1秒前
Sicily完成签到,获得积分10
1秒前
1秒前
LXL完成签到 ,获得积分10
2秒前
2秒前
饱满芷卉完成签到,获得积分10
3秒前
义气花生完成签到,获得积分10
3秒前
宝石山完成签到,获得积分10
5秒前
hugefrog完成签到,获得积分10
5秒前
6秒前
6秒前
不穷知识完成签到,获得积分10
7秒前
濮阳盼曼完成签到,获得积分0
7秒前
jiejie完成签到,获得积分10
7秒前
耸耸完成签到 ,获得积分10
8秒前
zq完成签到 ,获得积分10
8秒前
8秒前
JSEILWQ完成签到 ,获得积分10
8秒前
科研通AI6.4的应助被zhhl2006采纳,获得10
9秒前
特特特特特完成签到,获得积分10
9秒前
老毕完成签到,获得积分10
10秒前
彩色完成签到,获得积分10
10秒前
gcl完成签到,获得积分10
10秒前
Sweety完成签到,获得积分10
10秒前
小小酥被卷了完成签到,获得积分10
10秒前
胡杨完成签到,获得积分10
11秒前
今天值班的不是我完成签到,获得积分10
11秒前
的法国队完成签到,获得积分10
11秒前
yang的应助被龙抬头采纳,获得10
11秒前
zheng发布了新的文献求助10
12秒前
LU完成签到,获得积分10
13秒前
WY完成签到 ,获得积分10
13秒前
科研通AI6.4的应助被初景采纳,获得10
13秒前
兴奋鼠标完成签到 ,获得积分10
13秒前
chenamy完成签到,获得积分10
15秒前
木染完成签到,获得积分10
16秒前
寒冷的断缘完成签到,获得积分10
17秒前
120408完成签到 ,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173417
求助须知:如何正确求助?哪些是违规求助? 9565672
关于积分的说明 21781022
捐赠科研通 7767561
什么是DOI,文献DOI怎么找? 3431575
关于科研通互助平台的介绍 2555853
邀请新用户注册赠送积分活动 2476763